Use of psychotropic drugs during pregnancy - A report of the international co-operative drug use in pregnancy (DUP) study

F. Marchetti, M. Romero, M. Bonati, G. Tognoni

Research output: Contribution to journalArticle

34 Citations (Scopus)

Abstract

Drug Use in Pregnancy (DUP) is an international epidemiological survey of drug use in pregnancy conducted from 1988 to 1990 in 148 maternity wards, representing the general delivery practices of 22 countries. Data on exposure of pregnant women to psychotropic drugs, the indications for their use and their correlation with maternal characteristics are reported. Of the 14,778 women interviewed, 520 (3.5%) reported 562 courses of psychotropic drugs. Benzodiazepines (BDZ) accounted for the greatest number of the exposures (444/520 women); neuroleptics and antidepressants were prescribed to tiny minorities of women (83 and 17 respectively), mostly in those few countries were the overall prevalence of use of those drugs was highest. Throughout the majority of the other countries, overall rates were in the low range and were rather heterogeneous. With the exception of small clusters of "unexpected" indications, prescriptions of BDZ were found to be consistent with the target symptoms of anxiety and insomnia; chronic use was reported in 31/444 women. The study was not targeted to the detection of malformations; no suspected clustering was found, however, among the 130 women exposed during the first trimester of pregnancy. The collaborative network now established provides a framework for periodically replicated surveillance to monitor the evolution of this field of knowledge and care in order to provide reliable information for women and society.

Original languageEnglish
Pages (from-to)495-501
Number of pages7
JournalEuropean Journal of Clinical Pharmacology
Volume45
Issue number6
DOIs
Publication statusPublished - Dec 1993

Fingerprint

Psychotropic Drugs
Pregnancy
Pharmaceutical Preparations
Benzodiazepines
Sleep Initiation and Maintenance Disorders
First Pregnancy Trimester
General Practice
Antidepressive Agents
Antipsychotic Agents
Prescriptions
Cluster Analysis
Pregnant Women
Anxiety
Mothers

Keywords

  • drug utilisation
  • Pregnancy methodological
  • Psychotropic drugs

ASJC Scopus subject areas

  • Pharmacology, Toxicology and Pharmaceutics(all)
  • Pharmacology (medical)

Cite this

Use of psychotropic drugs during pregnancy - A report of the international co-operative drug use in pregnancy (DUP) study. / Marchetti, F.; Romero, M.; Bonati, M.; Tognoni, G.

In: European Journal of Clinical Pharmacology, Vol. 45, No. 6, 12.1993, p. 495-501.

Research output: Contribution to journalArticle

@article{03f89c6c926f490fb0c29f35c3fcb62c,
title = "Use of psychotropic drugs during pregnancy - A report of the international co-operative drug use in pregnancy (DUP) study",
abstract = "Drug Use in Pregnancy (DUP) is an international epidemiological survey of drug use in pregnancy conducted from 1988 to 1990 in 148 maternity wards, representing the general delivery practices of 22 countries. Data on exposure of pregnant women to psychotropic drugs, the indications for their use and their correlation with maternal characteristics are reported. Of the 14,778 women interviewed, 520 (3.5{\%}) reported 562 courses of psychotropic drugs. Benzodiazepines (BDZ) accounted for the greatest number of the exposures (444/520 women); neuroleptics and antidepressants were prescribed to tiny minorities of women (83 and 17 respectively), mostly in those few countries were the overall prevalence of use of those drugs was highest. Throughout the majority of the other countries, overall rates were in the low range and were rather heterogeneous. With the exception of small clusters of {"}unexpected{"} indications, prescriptions of BDZ were found to be consistent with the target symptoms of anxiety and insomnia; chronic use was reported in 31/444 women. The study was not targeted to the detection of malformations; no suspected clustering was found, however, among the 130 women exposed during the first trimester of pregnancy. The collaborative network now established provides a framework for periodically replicated surveillance to monitor the evolution of this field of knowledge and care in order to provide reliable information for women and society.",
keywords = "drug utilisation, Pregnancy methodological, Psychotropic drugs",
author = "F. Marchetti and M. Romero and M. Bonati and G. Tognoni",
year = "1993",
month = "12",
doi = "10.1007/BF00315304",
language = "English",
volume = "45",
pages = "495--501",
journal = "European Journal of Clinical Pharmacology",
issn = "0031-6970",
publisher = "Springer Verlag",
number = "6",

}

TY - JOUR

T1 - Use of psychotropic drugs during pregnancy - A report of the international co-operative drug use in pregnancy (DUP) study

AU - Marchetti, F.

AU - Romero, M.

AU - Bonati, M.

AU - Tognoni, G.

PY - 1993/12

Y1 - 1993/12

N2 - Drug Use in Pregnancy (DUP) is an international epidemiological survey of drug use in pregnancy conducted from 1988 to 1990 in 148 maternity wards, representing the general delivery practices of 22 countries. Data on exposure of pregnant women to psychotropic drugs, the indications for their use and their correlation with maternal characteristics are reported. Of the 14,778 women interviewed, 520 (3.5%) reported 562 courses of psychotropic drugs. Benzodiazepines (BDZ) accounted for the greatest number of the exposures (444/520 women); neuroleptics and antidepressants were prescribed to tiny minorities of women (83 and 17 respectively), mostly in those few countries were the overall prevalence of use of those drugs was highest. Throughout the majority of the other countries, overall rates were in the low range and were rather heterogeneous. With the exception of small clusters of "unexpected" indications, prescriptions of BDZ were found to be consistent with the target symptoms of anxiety and insomnia; chronic use was reported in 31/444 women. The study was not targeted to the detection of malformations; no suspected clustering was found, however, among the 130 women exposed during the first trimester of pregnancy. The collaborative network now established provides a framework for periodically replicated surveillance to monitor the evolution of this field of knowledge and care in order to provide reliable information for women and society.

AB - Drug Use in Pregnancy (DUP) is an international epidemiological survey of drug use in pregnancy conducted from 1988 to 1990 in 148 maternity wards, representing the general delivery practices of 22 countries. Data on exposure of pregnant women to psychotropic drugs, the indications for their use and their correlation with maternal characteristics are reported. Of the 14,778 women interviewed, 520 (3.5%) reported 562 courses of psychotropic drugs. Benzodiazepines (BDZ) accounted for the greatest number of the exposures (444/520 women); neuroleptics and antidepressants were prescribed to tiny minorities of women (83 and 17 respectively), mostly in those few countries were the overall prevalence of use of those drugs was highest. Throughout the majority of the other countries, overall rates were in the low range and were rather heterogeneous. With the exception of small clusters of "unexpected" indications, prescriptions of BDZ were found to be consistent with the target symptoms of anxiety and insomnia; chronic use was reported in 31/444 women. The study was not targeted to the detection of malformations; no suspected clustering was found, however, among the 130 women exposed during the first trimester of pregnancy. The collaborative network now established provides a framework for periodically replicated surveillance to monitor the evolution of this field of knowledge and care in order to provide reliable information for women and society.

KW - drug utilisation

KW - Pregnancy methodological

KW - Psychotropic drugs

UR - http://www.scopus.com/inward/record.url?scp=0027742815&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027742815&partnerID=8YFLogxK

U2 - 10.1007/BF00315304

DO - 10.1007/BF00315304

M3 - Article

C2 - 7908878

AN - SCOPUS:0027742815

VL - 45

SP - 495

EP - 501

JO - European Journal of Clinical Pharmacology

JF - European Journal of Clinical Pharmacology

SN - 0031-6970

IS - 6

ER -